These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 530529)

  • 41. Effects of chronic striatal kainate lesions on some dopaminergic parameters and enkephalin immunoreactive neurons in the basal ganglia.
    Schwarcz R; Fuxe K; Hökfelt T; Terenius L; Goldstein M
    J Neurochem; 1980 Apr; 34(4):772-8. PubMed ID: 6102111
    [No Abstract]   [Full Text] [Related]  

  • 42. Striatal ganglioside levels in the rat following kainic acid lesions: comparison with Huntington's disease.
    Higatsberger MR; Sperk G; Bernheimer H; Shannak KS; Hornykiewicz O
    Exp Brain Res; 1981; 44(1):93-6. PubMed ID: 6456150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intrastriatal kainic acid: acute effects on electrophysiological and biochemical measures of nigrostriatal dopaminergic activity.
    Braszko JJ; Bannon MJ; Bunney BS; Roth RH
    J Pharmacol Exp Ther; 1981 Feb; 216(2):289-93. PubMed ID: 6257886
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres.
    Chapman AG; Dürmuller N; Lees GJ; Meldrum BS
    Neurosci Lett; 1989 Dec; 107(1-3):256-60. PubMed ID: 2515501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kainic acid-induced lesion of dopaminergic target cells in the striatum: consequences on the dynamics of cerebellar cGMP.
    Biggio G; Corda MG; Casu M; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Aug; 304(1):5-7. PubMed ID: 211448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amphetamine-induced locomotor activity and stereotypy after kainic acid lesions of the striatum.
    Mason ST; Sanberg PR; Fibiger HC
    Life Sci; 1978 Feb; 22(6):451-9. PubMed ID: 24160
    [No Abstract]   [Full Text] [Related]  

  • 47. Changes in cholinergic but not in GABAergic markers in amygdala, piriform cortex, and nucleus basalis of the rat brain following systemic administration of kainic acid.
    Schliebs R; Zivin M; Steinbach J; Rothe T
    J Neurochem; 1989 Jul; 53(1):212-8. PubMed ID: 2542459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increase in striatal [3H]muscimol binding following intrastriatal injection of kainic acid: a denervation supersensitivity phenomenon.
    Kuriyama K; Kurihara E; Ito Y; Yoneda Y
    J Neurochem; 1980 Aug; 35(2):343-8. PubMed ID: 6256483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kainic acid: insights from a neurotoxin into the pathophysiology of Huntington's disease.
    Coyle JT; Ferkany JW; Zaczek R
    Neurobehav Toxicol Teratol; 1983; 5(6):617-24. PubMed ID: 6142425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure-activity relations for the neurotoxicity of kainic acid derivatives and glutamate analogues.
    Schwarcz R; Scholz D; Coyle JT
    Neuropharmacology; 1978 Feb; 17(2):145-51. PubMed ID: 634450
    [No Abstract]   [Full Text] [Related]  

  • 51. Age-related alterations in the rodent brain cholinergic system and behavior.
    Strong R; Hicks P; Hsu L; Bartus RT; Enna SJ
    Neurobiol Aging; 1980; 1(1):59-63. PubMed ID: 7266736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kainic acid and neurotransmitter interactions in the basal ganglia.
    McGeer PL; McGeer EG; Innanen VT
    Adv Biochem Psychopharmacol; 1980; 24():185-91. PubMed ID: 6105774
    [No Abstract]   [Full Text] [Related]  

  • 53. Cortical modulation of cholinergic neurons in the striatum.
    Simon JR
    Life Sci; 1982 Oct; 31(14):1501-8. PubMed ID: 7144438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kainic acid lesion of mouse striatum: effects on energy metabolites.
    Retz KC; Coyle JT
    Life Sci; 1980 Dec 22-29; 27(25-26):2495-500. PubMed ID: 6111722
    [No Abstract]   [Full Text] [Related]  

  • 55. Modification of drug-induced tremor by systemic administration of kainic acid and quisqualic acid in mice.
    Shinozaki H; Hirate K; Ishida M
    Neuropharmacology; 1987 Jan; 26(1):9-17. PubMed ID: 3550515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic taurine effects on various neurochemical indices in control and kainic acid-lesioned neostriatum.
    Sanberg PR; Staines W; McGeer EG
    Brain Res; 1979 Feb; 161(2):367-70. PubMed ID: 31967
    [No Abstract]   [Full Text] [Related]  

  • 57. Kainic acid selectively stimulates the release of endogenous excitatory acidic amino acids.
    Ferkany JW; Coyle JT
    J Pharmacol Exp Ther; 1983 May; 225(2):399-406. PubMed ID: 6842403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The striatonigral GABA pathway: functional and neurochemical characteristics in rats with unilateral striatal kainic acid lesions.
    Waddington JL; Cross AJ
    Eur J Pharmacol; 1980 Oct; 67(1):27-32. PubMed ID: 6252027
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of lesioning basal ganglia nuclei and output pathways on tremorine-induced tremor in rats.
    Slater P; Dickinson SL
    J Neurol Sci; 1982 Dec; 57(2-3):235-47. PubMed ID: 7161621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.